CJS Securities Starts TherapeuticsMD (TXMD) at Market Outperform
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Price: $2.08 --0%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
CJS Securities analyst Larry Solow initiates coverage on TherapeuticsMD (NASDAQ: TXMD) with a Market Outperform rating and a price target of $6.00.
For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.
Shares of TherapeuticsMD closed at $2.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Goldman Sachs Starts Vail Resorts (MTN) at Sell
- Canaccord Starts Galiano Gold (GAU:CN) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
